67 related articles for article (PubMed ID: 33994809)
1. Effects of prolonged treatment of TGF-βR inhibitor SB431542 on radiation-induced signaling in breast cancer cells.
Yadav P; Kundu P; Pandey VK; Amin PJ; Nair J; Shankar BS
Int J Radiat Biol; 2022 May; ():1-15. PubMed ID: 35446183
[TBL] [Abstract][Full Text] [Related]
2. Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer.
Li Z; Yang J; Chen L; Chen P; Liu C; Long X; Chen B; Long J
Anticancer Agents Med Chem; 2024 May; ():. PubMed ID: 38808719
[TBL] [Abstract][Full Text] [Related]
3. Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism.
Zou R; Gu R; Tu X; Chen J; Liu S; Xue X; Li W; Zhang Y
Discov Oncol; 2023 Aug; 14(1):162. PubMed ID: 37642715
[TBL] [Abstract][Full Text] [Related]
4. Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer.
Peng HH; Wang JN; Xiao LF; Yan M; Chen SP; Wang L; Yang K
Front Genet; 2021; 12():651647. PubMed ID: 33995485
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine CFF-1 exerts a potent anti-tumor immunity to hinder tumor growth and metastasis in prostate cancer through EGFR/JAK1/STAT3 pathway to inhibit PD-1/PD-L1 checkpoint signaling.
Zhang Y; Wei Y; Jiang S; Dang Y; Yang Y; Zuo W; Zhu Q; Liu P; Gao Y; Lu S
Phytomedicine; 2022 May; 99():153939. PubMed ID: 35172257
[TBL] [Abstract][Full Text] [Related]
6. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
[TBL] [Abstract][Full Text] [Related]
7. STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors.
Golus M; Bugajski P; Chorbińska J; Krajewski W; Lemiński A; Saczko J; Kulbacka J; Szydełko T; Małkiewicz B
Cells; 2022 Sep; 11(19):. PubMed ID: 36230984
[TBL] [Abstract][Full Text] [Related]
8. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
Zhou M; Zhang P; Da M; Yang R; Ma Y; Zhao J; Ma T; Xia J; Shen G; Chen Y; Chen D
Front Oncol; 2022; 12():925537. PubMed ID: 36176415
[TBL] [Abstract][Full Text] [Related]
9. Adapalene Inhibits Prostate Cancer Cell Proliferation
Nong HB; Zhang YN; Bai YG; Zhang Q; Liu MF; Zhou Q; Shi ZH; Zeng GF; Zong SH
Front Pharmacol; 2022; 13():801624. PubMed ID: 35273495
[No Abstract] [Full Text] [Related]
10. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
11. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
12. Normal Basal Epithelial Cells Stimulate the Migration and Invasion of Prostate Cancer Cell RM-1 by TGF-β1/STAT3 Axis in vitro.
Li CY; Chen CY; An JH; Wu JB; Shen H
Cancer Manag Res; 2021; 13():3685-3697. PubMed ID: 33994809
[TBL] [Abstract][Full Text] [Related]
13. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
[TBL] [Abstract][Full Text] [Related]
14. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
